Latest Share Purchase Plans News

L1 Group Limited has announced a $330 million equity raising to fund expansion initiatives, including new investment strategies and potential acquisitions, following its recent merger with Platinum Asset Management.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.

Canterbury Resources has successfully closed an oversubscribed Share Purchase Plan, raising $1.24 million to advance its copper-gold exploration projects across Australia and Papua New Guinea.

LGI Limited has launched a $5 million Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy additional shares at a slight discount. The capital raise aims to fund the acceleration of key renewable energy projects.

Miramar Resources advances its exploration portfolio with a new joint venture with Sumitomo Metal Mining and promising drilling results at key projects in Western Australia.

Strike Energy has made significant strides in its integrated gas-to-power strategy, advancing the South Erregulla Peaking Gas Power Station and securing a major $86 million investment from Carnarvon Energy. The company also confirmed a substantial 180 PJ contingent resource at Ocean Hill, positioning itself strongly in Western Australia's evolving energy market.

An application to the Takeovers Panel questions the integrity of Maronan Metals’ recent $16 million placement and its share purchase plan, raising concerns about undisclosed relationships and share price manipulation.

Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.

Arafura Rare Earths has launched a major A$475 million placement alongside a A$50 million share purchase plan, significantly advancing funding for its Nolans Project and edging closer to a Final Investment Decision in early 2026.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Centaurus Metals has achieved a major milestone with the granting of the Jaguar Nickel Sulphide Project mining lease and reported promising new copper-gold discoveries at its Boi Novo project, underpinning its growth ambitions in Brazil.